Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

B2B sales

- PMLiVE

Interview with Roch Doliveux, UCB

Why is patient-centricity placed at the heart of UCB? Jacky Law asked UCB’s CEO to explain his company’s philosophy

£775m funding for NHS research

The UK's Department of Health has announced £775m of funding over five years for scientific research to benefit NHS services

UK doctors worried by reform plans

A survey of British doctors has revealed that they are concerned about the effect proposed reforms will have on service

UK healthcare conferences stream live

The Nuffield Trust host its Annual Health Strategy Summit 2011 today as the King’s Fund holds its conference on telehealth

- PMLiVE

The missing link?

Commissioning for Quality and Innovation (CQUIN) can be linked to activity that can increase prescribing opportunities

Mistakes found in diabetes diagnoses

A report commissioned by the RCGP and NHS Diabetes has recommended new guidance on how diabetes is diagnosed in England, with around five per cent of current diagnoses found to...

- PMLiVE

NICE launches online GP resource

The UK's National Institute for Health and Clinical Excellence has launched a new online resource specifically for general practice, including a section for supporting GP consortia

DH appoints chair of Monitor

The UK's Department of Health has appointed Dr David Bennett as chair of Monitor, the independent regulator of foundation trusts

- PMLiVE

Politics of healthcare

Lansley needs to ensure his White Paper reforms are yielding dividends before the next election

Celgene’s Vidaza approved by NICE

Following improvements to its patient access scheme, NICE has changed its decision and recommended Vidaza (azacitidine) for the treatment of myelodysplastic syndromes (MDS)

NHS reforms threaten doctors’ education

Reforms to the NHS could have a negative effect on medical education and training in England, according to junior doctor leaders

Drugs access varies across England

Report finds wide differences in patient access to NICE-approved medicines

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links